Cargando…

Promising developments in neuropsychological approaches for the detection of preclinical Alzheimer’s disease: a selective review

Recently published guidelines suggest that the most opportune time to treat individuals with Alzheimer’s disease is during the preclinical phase of the disease. This is a phase when individuals are defined as clinically normal but exhibit evidence of amyloidosis, neurodegeneration and subtle cogniti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rentz, Dorene M, Parra Rodriguez, Mario A, Amariglio, Rebecca, Stern, Yaakov, Sperling, Reisa, Ferris, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978443/ https://www.ncbi.nlm.nih.gov/pubmed/24257331 http://dx.doi.org/10.1186/alzrt222

Ejemplares similares

Optimizing the preclinical Alzheimer's cognitive composite with semantic processing: The PACC5
por: Papp, Kathryn V., et al.
Publicado: (2017)

Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease
por: Samaroo, Aubryn, et al.
Publicado: (2021)

Monthly At-Home Computerized Cognitive Testing to Detect Diminished Practice Effects in Preclinical Alzheimer's Disease
por: Jutten, Roos J., et al.
Publicado: (2022)

Relation of modifiable lifestyle and mood factors to cognitive concerns among participants and their study partners in the A4 screen data
por: Reynolds, Gretchen, et al.
Publicado: (2023)

Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer’s disease
por: Halawa, Omar A., et al.
Publicado: (2019)

Longitudinal Trajectories of Participant- and Study Partner-Rated Cognitive Decline, in Relation to Alzheimer’s Disease Biomarkers and Mood Symptoms
por: Munro, Catherine E., et al.
Publicado: (2022)

Disparities by Race and Ethnicity Among Adults Recruited for a Preclinical Alzheimer Disease Trial
por: Raman, Rema, et al.
Publicado: (2021)

Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease
por: Papp, Kathryn V., et al.
Publicado: (2021)

Computerized cognitive practice effects in relation to amyloid and tau in preclinical Alzheimer's disease: Results from a multi‐site cohort
por: Young, Christina B., et al.
Publicado: (2023)

The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer’s disease
por: Vila-Castelar, Clara, et al.
Publicado: (2020)

Amyloid-associated increases in longitudinal report of subjective cognitive complaints
por: Amariglio, Rebecca E., et al.
Publicado: (2018)

Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease
por: Norton, Daniel J., et al.
Publicado: (2020)

Neuroimaging correlates of Stages of Objective Memory Impairment (SOMI) system
por: Grober, Ellen, et al.
Publicado: (2021)

Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study
por: Hanseeuw, Bernard J., et al.
Publicado: (2019)

Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging
por: Vannini, Patrizia, et al.
Publicado: (2017)

Structural tract alterations predict down-stream tau accumulation in amyloid positive older individuals
por: Jacobs, Heidi I.L., et al.
Publicado: (2018)

Measuring instrumental activities of daily living in non-demented elderly: a comparison of the new performance-based Harvard Automated Phone Task with other functional assessments
por: Marshall, Gad A., et al.
Publicado: (2019)

Association of anxiety with subcortical amyloidosis in cognitively normal older adults
por: Hanseeuw, Bernard J., et al.
Publicado: (2018)

Correction: Association of anxiety with subcortical amyloidosis in cognitively normal older adults
por: Hanseeuw, Bernard J., et al.
Publicado: (2018)

Multiple markers contribute to risk of progression from normal to mild cognitive impairment
por: Rabin, Jennifer S., et al.
Publicado: (2020)

Commentary on Composite cognitive and functional measures for early stage Alzheimer's disease trials
por: Rentz, Dorene M., et al.
Publicado: (2020)

Decreased meta-memory is associated with early tauopathy in cognitively unimpaired older adults
por: Vannini, Patrizia, et al.
Publicado: (2019)

Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study
por: Marshall, Gad A., et al.
Publicado: (2020)

Neuropsychological assessment in preclinical and prodromal Alzheimer disease: a global perspective
por: Watermeyer, Tamlyn, et al.
Publicado: (2019)

APOE effects on regional tau in preclinical Alzheimer’s disease
por: Young, Christina B., et al.
Publicado: (2023)

Cognition, Reserve, and Amyloid Deposition in Normal Aging
por: Rentz, Dorene M, et al.
Publicado: (2010)

Longitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults
por: Gatchel, Jennifer R., et al.
Publicado: (2019)

Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study
por: Buckley, Rachel F., et al.
Publicado: (2019)

Pro: Can biomarkers be gold standards in Alzheimer's disease?
por: Sperling, Reisa, et al.
Publicado: (2010)

Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease
por: Assunção, Sheila Seleri, et al.
Publicado: (2022)

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum
por: Dubbelman, Mark A., et al.
Publicado: (2020)

Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study
por: Grober, Ellen, et al.
Publicado: (2022)

Racial and socioeconomic status differences in stress, posttraumatic growth, and mental health in an older adult cohort during the COVID-19 pandemic
por: Willey, Brea, et al.
Publicado: (2022)

Validating Use of Technology for Cognitive Test Assessment
por: Rentz, Dorene M.
Publicado: (2016)

Development and Validation of a Deep Learning Model for Earlier Detection of Cognitive Decline From Clinical Notes in Electronic Health Records
por: Wang, Liqin, et al.
Publicado: (2021)

P300 and Neuropsychological Assessment in Mild Cognitive Impairment and Alzheimer Dementia
por: Parra, Mario A., et al.
Publicado: (2012)

Integrated Alzheimer's Disease Rating Scale: Clinically meaningful change estimates
por: Wessels, Alette M., et al.
Publicado: (2022)

Functional MRI Assessment of Task-Induced Deactivation of the Default Mode Network in Alzheimer’s Disease and At-Risk Older Individuals
por: Pihlajamäki, Maija, et al.
Publicado: (2009)

Large-Scale Functional Brain Network Abnormalities in Alzheimer’s Disease: Insights from Functional Neuroimaging
por: Dickerson, Bradford C., et al.
Publicado: (2009)

Regional tau pathology and loneliness in cognitively normal older adults
por: d’Oleire Uquillas, Federico, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k9qt0d4eogpmh9m24udp511rqp